nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressure-independent mechanism
|
Yen, T-H |
|
2013 |
22 |
2 |
p. 180-189 |
artikel |
2 |
Anti-erythropoietin receptor antibodies in systemic lupus erythematosus patients with anemia
|
Luo, X-Y |
|
2013 |
22 |
2 |
p. 121-127 |
artikel |
3 |
Association of the interleukin-10 gene polymorphism (–1082A/G) with systemic lupus erythematosus: a meta-analysis
|
Zhou, M |
|
2013 |
22 |
2 |
p. 128-135 |
artikel |
4 |
Cardiac valve vegetations in APS, role of long-term anticoagulation
|
Musuruana, JL |
|
2013 |
22 |
2 |
p. 223-225 |
artikel |
5 |
Causes of mortality among inpatients with systemic lupus erythematosus in a tertiary care hospital in North India over a 10-year period
|
Sharma, A |
|
2013 |
22 |
2 |
p. 216-222 |
artikel |
6 |
Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation
|
Becker-Merok, A |
|
2013 |
22 |
2 |
p. 155-163 |
artikel |
7 |
Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil
|
Daleboudt, GMN |
|
2013 |
22 |
2 |
p. 171-179 |
artikel |
8 |
Extent and characteristics of self-reported pain in patients with systemic lupus erythematosus
|
Waldheim, E |
|
2013 |
22 |
2 |
p. 136-143 |
artikel |
9 |
HLA variants rs9271366 and rs9275328 are associated with systemic lupus erythematosus susceptibility in Malays and Chinese
|
Chai, HC |
|
2013 |
22 |
2 |
p. 198-204 |
artikel |
10 |
Intracranial hypertension associated with systemic lupus erythematosus in a young male patient
|
Tse, C |
|
2013 |
22 |
2 |
p. 205-212 |
artikel |
11 |
MicroRNA-101, mitogen-activated protein kinases and mitogen-activated protein kinases phosphatase-1 in systemic lupus erythematosus
|
Yang, J |
|
2013 |
22 |
2 |
p. 115-120 |
artikel |
12 |
Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus
|
Doherty, T |
|
2013 |
22 |
2 |
p. 213-215 |
artikel |
13 |
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
|
Wallace, DJ |
|
2013 |
22 |
2 |
p. 144-154 |
artikel |
14 |
Validation of the Portuguese Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY) in Brazil
|
Moorthy, LN |
|
2013 |
22 |
2 |
p. 190-197 |
artikel |
15 |
Weight change associated with corticosteroid therapy in adolescents with systemic lupus erythematosus
|
Manaboriboon, B |
|
2013 |
22 |
2 |
p. 164-170 |
artikel |